Alzheimer's Association International Conference on Alzheimer's Disease 2015 (AAIC 2015) (July 18-23, 2015 - Washington, D.C., USA).
The Alzheimer's Association International Conference (AAIC) was held in Washington, D.C. this year. It is the world's largest meeting of the dementia research community, connecting care providers, clinicians and investigators. The extent of efforts being made in the field of Alzheimer's research was demonstrated by the wide and varied program at the conference. This report focuses on some of the therapeutic highlights from the first two poster sessions.
Thomson Reuters, London, UK. scientific.prousjournals@thomsonreuters.com.
V L
VL
Mason
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography; D017480:Receptors, sigma; D000097605:Sigma-1 Receptor
D061067:Antibodies, Monoclonal, Humanized; D019788:Fluorodeoxyglucose F18; D017480:Receptors, sigma; D000097605:Sigma-1 Receptor; C550616:solanezumab
ANAVEX2-73; BI-409306; E-2609; Flutafuranol F 18; S-44858; SUVN-G3031; Solanezumab; T-817MA; TTP-488